-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The International Multiple Sclerosis Microbiome Research (iMSMS) consortium recently published an article in the journal Cell that the gut microbiome composition of patients with multiple sclerosis varies
The etiology of multiple sclerosis (MS) remains unclear, but it is generally accepted that both genetic and environmental factors influence the development of
Sergio Baranzini, a professor of neurology at the University of California, San Francisco, and colleagues at iMSMS wrote in the paper: "These results strongly support a specific association
The iMSMS consortium recruited 576 MS patients and 576 healthy controls within the same family from seven different centers in the United States, South America and Europe and collected stool samples
In untreated MS patients with untreated MS, there were more than a dozen microorganisms increased and six decreased
They also found that there were few differences between the functional potential of microbes, but differences
Many microorganisms, including Akkermansia muciniphila, degrade phytates
The treatments received by MS patients further affect their gut microbiome
The researchers also examined the effects of diet on the composition of the gut microbiome of MS and found that while MS patients tended to eat healthier diets than controls in the same household, diet had little
Baranzini and colleagues added: "The findings strongly support the association
Source text search
Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course